TITLE

HPV vaccine and anal cancer risk

PUB. DATE
December 2011
SOURCE
Travel Medicine Advisor;Dec2011 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Prevention and Control (CDC) to administer human papillomavirus (HPV) vaccines to 11- and 12-year-old boys in the U.S. It is inferred that the HPV vaccine reduces the risk of genital warts in men and cervical cancer in women. A double-blind study is highlighted in which HPV vaccine decreases the risk of anal intraepithelial neoplasia among men who have sex with men.
ACCESSION #
67762810

 

Related Articles

  • HPV Vaccine Now Recommended for Males.  // Neurology Alert;Dec2011 Pharmacology Watch, p1 

    The article reports on the recommendation issued by the U.S. Center for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices approving the administration of human papillomavirus (HPV) vaccine for 11- and 12-year old boys. The committee found the efficacy of the...

  • HPV Vaccine Now Recommended for Males.  // Infectious Disease Alert;Dec2011 Pharmacology Watch, p1 

    The article reports that the U.S. Advisory Committee on Immunization Practices has recommended the routine use of human papillomavirus (HPV) vaccine in boys aged 11 and 12. Diseases associated with HPV are genital warts and cervical cancer. A study found that anal intraepithelial neoplasia in...

  • HPV vaccine and anal cancer risk. Elliott, William T. // Infectious Disease Alert;Nov2011 Pharmacology, p1 

    The article reports on the new recommendations for human papillomavirus (HPV) vaccine in the U.S. It states that the Advisory Committee on Immunization Practices at the U.S. Centers for Disease Control (CDC) has recommended the vaccine for young boys. The committee perceives that the vaccine...

  • HPV vaccine and anal cancer risk.  // Internal Medicine Alert;11/15/2011 Supplement, p1 

    The article reports on the recommendation by the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices for the human papillomavirus (HPV) vaccine for 11- and 12-year old boys.

  • FDA may decide on HPV vaccination in 27- to 45-year-old women by mid-2010. Volansky, Rob // Infectious Disease News;Mar2010, Vol. 23 Issue 3, p14 

    This article reports on the move of the U.S. Advisory Committee on Immunization Practices to discuss the use of the quadrivalent human papillomavirus vaccine in women aged 27 to 45 years.

  • Bivalent HPV vaccine recommended. Blazek, Nicole; Zacharyczuk, Colleen // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p35 

    The article reports that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended the use of bivalent human papillomavirus vaccine in the prevention of cervical cancer in girls and women ages 10-25 years.

  • Update on Vaccination Against Human Papillomavirus (HPV). Weber, Carol J. // Urologic Nursing;Aug2007, Vol. 27 Issue 4, p320 

    The article presents information on the U.S. Advisory Committee on Immunization Practices' (ACIP) guidelines for compulsory vaccination of girls and young women against the human papillomavirus (HPV). Many U.S. states have responded positively by making vaccination a condition of enrollment for...

  • Update on Immunizations in Adults. VAUGHN, JOHN A.; MILLER, ROGER A. // American Family Physician;11/1/2011, Vol. 84 Issue 9, p1015 

    The article presents updates from the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention on its recommended annual adult immunization schedule. These updates include the permissive but not routine use of quadrivalent human papillomavirus vaccine...

  • Update on ACIP Adult Immunization Guidelines. Kemper, Carol A. // Infectious Disease Alert;Mar2010 Updates, p71 

    The article reports on the revised Adult Vaccination Schedule of the Advisory Committee on Immunization Practices (ACIP) in the U.S. that was published on January 5, 2010. The committee has approved a second human papillomavirus (HPV) vaccine for young adults which includes only two HPV strains...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics